Oxycodone/dextromethorphan - Endo

Drug Profile

Oxycodone/dextromethorphan - Endo

Alternative Names: EN-3229; OxycoDex

Latest Information Update: 04 Feb 2008

Price : $50

At a glance

  • Originator Endo Pharmaceuticals
  • Class Morphinans; Morphine derivatives; Opioid analgesics; Small molecules
  • Mechanism of Action NMDA receptor antagonists; Opioid delta receptor agonists; Opioid kappa receptor agonists; Opioid mu receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Discontinued Pain

Most Recent Events

  • 11 Jul 2006 No development reported - Phase-II for Pain in USA (PO)
  • 06 Aug 2002 Phase-II clinical trials in Pain in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top